Medpace Holdings, Inc. (MEDP)
600.65
-10.92
(-1.79%)
USD |
NASDAQ |
Aug 28, 16:00
599.44
-1.21
(-0.20%)
Pre-Market: 20:00
Medpace Holdings Free Cash Flow : 706.69M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 706.69M |
| March 31, 2026 | 711.00M |
| December 31, 2025 | 681.87M |
| September 30, 2025 | 676.77M |
| June 30, 2025 | 579.82M |
| March 31, 2025 | 540.93M |
| December 31, 2024 | 572.27M |
| September 30, 2024 | 535.65M |
| June 30, 2024 | 502.80M |
| March 31, 2024 | 473.34M |
| December 31, 2023 | 396.73M |
| September 30, 2023 | 377.76M |
| June 30, 2023 | 373.39M |
| March 31, 2023 | 384.74M |
| December 31, 2022 | 351.17M |
| September 30, 2022 | 285.51M |
| June 30, 2022 | 249.91M |
| March 31, 2022 | 221.24M |
| December 31, 2021 | 235.06M |
| September 30, 2021 | 270.99M |
| June 30, 2021 | 256.37M |
| March 31, 2021 | 234.56M |
| Date | Value |
|---|---|
| December 31, 2020 | 227.34M |
| September 30, 2020 | 180.80M |
| June 30, 2020 | 187.84M |
| March 31, 2020 | 196.06M |
| December 31, 2019 | 183.96M |
| September 30, 2019 | 168.77M |
| June 30, 2019 | 160.36M |
| March 31, 2019 | 152.70M |
| December 31, 2018 | 140.56M |
| September 30, 2018 | 129.82M |
| June 30, 2018 | 116.74M |
| March 31, 2018 | 109.49M |
| December 31, 2017 | 85.09M |
| September 30, 2017 | 83.21M |
| June 30, 2017 | 86.60M |
| March 31, 2017 | 63.98M |
| December 31, 2016 | 78.20M |
| September 30, 2016 | 80.28M |
| June 30, 2016 | 70.00M |
| March 31, 2016 | 98.50M |
| December 31, 2015 | 85.87M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| IQVIA Holdings, Inc. | 2.184B |
| Charles River Laboratories International, Inc. | 370.60M |
| Avantor, Inc. | 454.70M |
| Champions Oncology, Inc. | -5.036M |
| Personalis, Inc. | -100.98M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 162.01M |
| Cash from Investing (Quarterly) | -23.88M |
| Cash from Financing (Quarterly) | -288.34M |
| Free Cash Flow Per Share (Quarterly) | 4.836 |
| Free Cash Flow to Equity (Quarterly) | 140.08M |
| Free Cash Flow to Firm (Quarterly) | 138.10M |
| Free Cash Flow Yield | 4.08% |